Back to results
US 2026/0085066 A1Published application
Leucine rich repeat kinase 2 (lrrk2) degrading compounds and associated methods of use
AssigneeArvinas Operations, Inc.
InventorsSteven M. Sparks, Handing Dong, Michael Berlin
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to bifunctional compounds that cause the degradation of LRRK2; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with LRRK2, including Parkinson's Disease.
Claims11
A compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.